Steven Cohen’s Jade Biosciences JBIO Stock Holding History

Steven Cohen’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.72M	Sell	167,204 -97,111	-37%	-$2.03M	﹤0.01%	1981
2026 Q1	$3.71M	Sell	264,315 -294,159	-53%	-$4.26M	﹤0.01%	1903
2025 Q4	$8.62M	Buy	+558,474	New	+$6.55M	0.01%	1449
2024 Q2	–	Sell	-11,424	Closed	-$11.8M	–	1857
2024 Q1	$11.8M	Sell	11,424 -1,190	-9%	-$909K	0.03%	655
2023 Q4	$9.99M	Buy	+12,614	New	+$6.43M	0.02%	686
2023 Q2	–	Sell	-1,975	Closed	-$1.39M	–	2170
2023 Q1	$1.39M	Sell	1,975 -3,026	-61%	-$2.51M	﹤0.01%	1050
2022 Q4	$5.13M	Buy	+5,001	New	+$3.63M	0.02%	749
2021 Q4	–	Sell	-1,539	Closed	-$1.13M	–	1085
2021 Q3	$1.13M	Buy	+1,539	New	+$862K	0.01%	842

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steven Cohen's JBIO Position: Q2 2026 in Review

Steven Cohen reduced its Jade Biosciences (JBIO) stake by 37% in Q2 2026, selling an estimated $2.03M and leaving 167,204 shares worth $3.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1981.

Steven Cohen first reported a position in JBIO in Q3 2021 and has held it in 8 quarters since. The position peaked at $11.8M in Q1 2024. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

Steven Cohen held 167,204 shares of Jade Biosciences worth $3.72M as of Q2 2026.
Steven Cohen sold 97,111 Jade Biosciences shares in Q2 2026, an estimated $2.03M.
Jade Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #1981 holding.
Steven Cohen first reported a position in Jade Biosciences in Q3 2021 and has held it in 8 quarters since.
Steven Cohen's Jade Biosciences position peaked at $11.8M in Q1 2024.
153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.